Prostate Cancer ADT Has Fewer Cardiovascular Risks Than Expected
Investigators found that men receiving androgen deprivation therapy for prostate cancer had a 1% rate of major adverse cardiovascular events.
PROSTATE CANCER ADVISOR
Prostate Cancer
Features
-
-
Video May Aid in Precision Medicine for Prostate Cancer
In a study of men with prostate cancer or a family history of the disease, a higher proportion of men opted to view an educational video over personal genetic counseling prior to genetic testing. -
PSA Density Plus MRI May Improve Detection of Clinically Significant Prostate Cancer
Combining PSA density with prostate MRI findings improves the predictive performance of PI-RADS in men without a prior prostate cancer diagnosis. -
4Kscore May Help Predict Adverse Pathology at Radical Prostatectomy
In a study, a higher 4Kscore was significantly associated with a 16% greater risk of biochemical recurrence of prostate cancer following radical prostatectomy. -
SABR Found to Improve Outcomes in Recurrent Oligometastatic HSPC
In patients with recurrent oligometastatic hormone-sensitive prostate cancer, stereotactic ablative radiation therapy decreased the risk of disease progression compared with observation alone, a phase 2 study found. -
Genomic Alterations Linked to Outcomes in mCSPC
DNA sequencing in men with metastatic castration-sensitive prostate cancer revealed alterations in certain signaling pathways that predict worse overall survival and shorter progression time to castration-resistant disease. -
Prostate Cancer Immunotherapy Alone Is Not Enough
So far, prostate cancer immunotherapy has shown only modest benefits. To greatly improve outcomes, immunotherapy will need to be combined with other treatments, according to the authors of a recent review. -
Radiation Therapy After Prostate Surgery Worsens Sexual, Urinary Function
Allowing an approximately 24-month recovery period after prostate surgery before giving radiation therapy may be optimal for preserving erectile function provided oncologic control is not compromised, according to investigators.
Latest Prostate Cancer News
PSA Screening for Prostate Cancer Beneficial, Especially for Black Men
In all studied scenarios, PSA screening appeared more favorable for Black men than for the general population.
Active Surveillance Rate for Low-Risk Prostate Cancer Is Rising
Although most men with low-risk prostate cancer are now managed initially with active surveillance, use of this approach remains suboptimal, according to investigators.
Study: Confirmatory Prostate Biopsies Still Needed Despite Upfront MRI
New findings challenge recommendations from the European Association of Urology.
Prostate Cancer Upgrading on AS Linked to Perineural Invasion
The presence of perineural invasion in a prostate biopsy has important implications for active surveillance.
Prostate Cancer Upgrading Risk in Active Surveillance Does Not Differ by Race
Active surveillance appears to be a safe treatment option for low- and very low-risk prostate cancer, regardless of race, according to investigators.
Negative MRI in Active Surveillance Often Predicts Stable Prostate Cancer
Some patients with a negative mpMRI while on prostate cancer active surveillance may be able to defer biopsy, according to investigators.
PSA Bounce vs Biochemical Recurrence After Prostate Cancer SBRT Probed
Study reveals factors that could distinguish PSA bounce from biochemical recurrence after stereotactic body radiation therapy for prostate cancer.
Prostate Cancer Grade Migration Documented
Grade group 1 prostate cancers declined as a proportion of all prostate cancers.
Metastatic Prostate Cancer Survival Improved in Wake of Treatment Advances
Following the approval of cabazitaxel in 2010, there are now an unprecedented number of life-prolonging therapies for men with metastatic disease.
Prostate, Bladder Cancer Care Delays Common During Pandemic
Study characterized patient-reported delays in care of prostate cancer and bladder cancer at the national level.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Prostate Cancer
Loading... 
Loading...